How much does a bottle of Vandetanib cost?

Vandetanib is a small molecule multi-target tyrosine kinase inhibitor that was approved by the US FDA in April 2011. It is mainly used to treat unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC). Medullary thyroid cancer (thyroid cancer), as a relatively rare malignant thyroid tumor, progresses rapidly. Traditional treatments such as surgery are often difficult to completely remove the lesions in advanced patients. Therefore, the emergence of targeted therapy drugs is of great significance in improving prognosis. The clinical application of vandetanib is not only reflected in delaying disease progression, but also improving tumor-related symptoms to a certain extent, bringing more survival benefits to patients.

From the perspective of drug properties, vandetanib simultaneously inhibits EGFR, VEGFR and RET signaling pathways, cutting off the growth and angiogenesis process of tumor cells, and ultimately blocking tumor progression. This multi-target mechanism makes it clinically more advantageous than single-target drugs, especially in the complex microenvironment of thyroid cancer, which can act from multiple angles. International guidelines have listed it as one of the important treatment options for patients with advanced medullary thyroid cancer.

In terms of price, the specification of vandetanib tablets sold overseas is 300mg*30 tablets, and the price of one bottle is about 45,000 yuan, which is also the core issue that most patients are concerned about. At present, the drug has not been officially launched in the country, so it cannot enter the medical insurance reimbursement system. For domestic patients, if they need to use vandetanib, they can only obtain it through overseas channels or designated imported drug channels, which poses challenges in terms of cost and convenience. More importantly, there are currently no imitation versions on the market, which keeps prices high for a long time and puts a heavy financial burden on patients.

Reference materials:https://www.drugs.com/caprelsa.html